The Gut Microbiome Is Associated with Clinical Response to Anti-PD-1/PD-L1 Immunotherapy in Gastrointestinal Cancer/Experiment 5/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by Folakunmi on 2024-4-9

Curated date: 2024/03/30

Curator: Scholastica

Revision editor(s): Scholastica

Source: Supp. Table S10

Description: Differential abundance between responders and non-responders to Anti–PD-1/PD-L1 immunotherapy in patients with Gastrointestinal Cancer (Responders, n=25; Non-responders, n=15)

Abundance in Group 1: decreased abundance in Non-responders to anti–PD-1/PD-L1 immunotherapy

NCBI	Quality Control	Links
Agathobacter rectalis
Clostridium perfringens
Eubacterium ramulus
Limosilactobacillus mucosae
Parabacteroides distasonis
Rothia dentocariosa
Streptococcus anginosus
Streptococcus sanguinis
Streptococcus vestibularis
unclassified Granulicatella
Coprococcus catus
Dorea longicatena
Erysipelotrichaceae bacterium 6_1_45
Akkermansia muciniphila

Revision editor(s): Scholastica